New Delhi: The celebrations of this World Heart Day (29 September, 2024) belong to a ‘made in India’ stent Supraflex Cruz. This top- notch stent made by numero uno cardiac technology Indian company Sahajanand Medical Technologies (SMT), deserves to be feted on this crucial heart day because of its victory of quality court battle fought in Europe not long ago.
This stent was targeted in Europe by a cabal of deep pocket and well entrenched multinational stent maker rivals in cahoots with certification agency there. This life saving cardiac medical device is used in angioplasty to open the blocked artery of heart. In a pitched court battle, its superior quality became its salvation.
This trail blazer stent has brought laurel to Make in India as never before. It is now a badge of honor on India and its maker SMT. This victory in court battle is the most stentorian voice of Make in India in Europe. Add to this, its recent triumphal march in Australia . Hot on the heels of this super victory, another member of Supraflex family of stent Supraflex Cruz DES has just bagged regulatory approval in Australia. Getting foothold in Down Under is not a mean achievement because its quite strict quality testing regime is . For Supraflex Cruz stent maker SMT, the world is the oyster now.
These back to back two recent events have steeled SMT’s resolve for world conquest in medical device domain. Rajiv Chhibbar, Vice President of SMT said, ‘SMT is so possessed by magical call of Make in India by PM Modi that it is not going to rest on its laurels. We are primed to pull off many such accomplishments and are sworn to go forward for making India hub of medical device as it is already pharmacy of the world. We are also making strides in other cardiac medical devices including best of class heart valve. We won court battle in Europe by virtue of being super in quality. We had no one to lean on save and except our quality.’
The reason of Supraflex Cruz being the target was, by sheer virtue of its supreme quality, it quickly capitalizing on the European stent market which resulted into shrinking that of its multinational market. They were desperate to halt the triumphal march of the thinnest stent in the world and stooped to conquer by resorting to conspiracy. In addition to its quality, this triumph also speaks volume about the resilience of SMT.
SMT’s stent is one of the very few made in India medical devices which are killing it in Europe. Rajiv further says, ‘ Supraflex Cruz is amongst the top 5 stents in Europe, and in a few top countries we have leading position. Of course in India we are the top ranked and widely used stent in India with a market share of over 30 percent’.
